Avicanna Secures $800K in Private Placement
Company Announcements

Avicanna Secures $800K in Private Placement

Story Highlights

Avicanna (TSE:AVCN) has released an update.

Avicanna Inc., a global biopharmaceutical company, has successfully closed a non-brokered private placement, raising $800,010 through the sale of units priced at $0.30 each. The funds will support the company’s operational and developmental activities, including production, manufacturing, and research. Avicanna’s diverse portfolio spans medical cannabis products, a pharmaceutical pipeline, and active pharmaceutical ingredients, underpinning its international market presence.

For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAvicanna Launches Major Cannabis Effects Study
TheFlyAvicanna announces medical cannabis real world evidence study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App